Acasunlimab

• Target :

  PD-1/PD-L1

• Related Pathways :

  Apoptosis|||Cell Cycle/Checkpoint|||Immunology/Inflammation

• Bioactivity :

  Acasunlimab (GEN1046), a bispecific antibody (bsAb) designed to target PD-L1 and 4-1BB, functions by enhancing both T-cell and NK-cell response via conditional 4-1BB stimulation and continuously inhibiting the PD-1/PD-L1 axis. This compound is applicable in cancer research [1] [2].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2253937-12-9